(Q37216488)

19 August 2017

1 reference

title

Th17 cells: a new therapeutic target in inflammatory dermatoses (English)

1 reference

19 August 2017

0 references

Adam Asarch

1

1 reference

19 August 2017

Orr Barak

series ordinal

2

1 reference

19 August 2017

Daniel S Loo

series ordinal

3

1 reference

19 August 2017

Alice B Gottlieb

series ordinal

4

1 reference

19 August 2017

1 January 2008

1 reference

Journal of Dermatological Treatment

19 August 2017

1 reference

19 August 2017

19

1 reference

19 August 2017

6

1 reference

19 August 2017

318-326

1 reference

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Interleukin-17 in inflammatory skin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Interleukin-15: a new cytokine target for the treatment of inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Immunopathogenesis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: results from the Roxbury lupus project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Swords into plowshares: IL-23 repurposes tumor immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

IL-23 promotes tumour incidence and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Rheumatoid arthritis in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Humanized antihuman IL-6 receptor antibody, tocilizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

The clinical role of IL-23p19 in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

New cytokine targets in inflammatory rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn?s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

IL-17 as a potential target for modulating airway neutrophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

IL-22 increases the innate immunity of tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

Three decades of psoriasis research: where has it led us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802206660

10.1080/09546630802206660

21 January 2018

Identifiers

DOI

1 reference

release_vvppdpw3bngnngfajdheczjr3q

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vvppdpw3bngnngfajdheczjr3q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference